The global NGS Based Clinical Diagnostics market size is projected to reach US$ XX million by 2028, from US$ XX million in 2021, at a CAGR of XX during 2022-2028.
Fully considering the economic change by this health crisis, DNA Sequencing accounting for xx% of the NGS Based Clinical Diagnostics global market in 2021, is projected to value US$ xx million by 2028, growing at a revised xx% CAGR in the post-COVID-19 period. While Hospitals segment is altered to an xx % CAGR throughout this forecast period.
China NGS Based Clinical Diagnostics market size is valued at US$ xx million in 2021, while the North America and Europe NGS Based Clinical Diagnostics are US$ xx million and US$ xx million, severally. The proportion of the North America is xx% in 2021, while China and Europe are xx% and xx% respectively, and it is predicted that China proportion will reach xx% in 2028, trailing a CAGR of xx % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR xx%, xx%, and xx % respectively for the next 6-year period. As for the Europe NGS Based Clinical Diagnostics landscape, Germany is projected to reach US$ xx million by 2028 trailing a CAGR of xx % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS Based Clinical Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS Based Clinical Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS Based Clinical Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS Based Clinical Diagnostics market.
Global NGS Based Clinical Diagnostics Scope and Market Size
NGS Based Clinical Diagnostics market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NGS Based Clinical Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
Segment by Type
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
Segment by Application
Hospitals
Clinics
Others
BY REGION
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX
Table of Contents 1 Report Overview 1 1.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global NGS Based Clinical Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1 1.2.2 DNA Sequencing 3 1.2.3 RNA Sequencing 3 1.2.4 Whole Genome Sequencing 3 1.2.5 Whole Exome Sequencing 4 1.2.6 Other 4 1.3 Market by Application 5 1.3.1 Global NGS Based Clinical Diagnostics Market Share by Application: 2017 VS 2021 VS 2028 5 1.3.2 Hospitals 6 1.3.3 Clinics 6 1.3.4 Others 7 1.4 Study Objectives 7 1.5 Years Considered 7 2 Global Growth Trends 9 2.1 Global NGS Based Clinical Diagnostics Market Perspective (2017-2028) 9 2.2 NGS Based Clinical Diagnostics Growth Trends by Region 10 2.2.1 NGS Based Clinical Diagnostics Market Size by Region: 2017 VS 2021 VS 2028 10 2.2.2 NGS Based Clinical Diagnostics Historic Market Size by Region (2017-2022) 11 2.2.3 NGS Based Clinical Diagnostics Forecasted Market Size by Region (2023-2028) 12 2.3 NGS Based Clinical Diagnostics Market Dynamics 12 2.3.1 NGS Based Clinical Diagnostics Industry Trends 12 2.3.2 NGS Based Clinical Diagnostics Market Drivers 13 2.3.3 NGS Based Clinical Diagnostics Market Challenges 13 2.3.4 NGS Based Clinical Diagnostics Market Restraints 14 3 Competition Landscape by Key Players 15 3.1 Global Top NGS Based Clinical Diagnostics Players by Revenue 15 3.1.1 Global Top NGS Based Clinical Diagnostics Players by Revenue (2017-2022) 15 3.1.2 Global NGS Based Clinical Diagnostics Revenue Market Share by Players (2017-2022) 16 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 4 3.2 Global NGS Based Clinical Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 16 3.3 Players Covered: Ranking by NGS Based Clinical Diagnostics Revenue 18 3.4 Global NGS Based Clinical Diagnostics Market Concentration Ratio 19 3.4.1 Global NGS Based Clinical Diagnostics Market Concentration Ratio (CR5 and HHI) 19 3.4.2 Global Top 10 and Top 5 Companies by NGS Based Clinical Diagnostics Revenue in 202120 3.5 NGS Based Clinical Diagnostics Key Players Head office and Area Served 21 3.6 Key Players NGS Based Clinical Diagnostics Product Solution and Service 21 3.7 Date of Enter into NGS Based Clinical Diagnostics Market 22 3.8 Mergers & Acquisitions, Expansion Plans 22 4 NGS Based Clinical Diagnostics Breakdown Data by Type 24 4.1 Global NGS Based Clinical Diagnostics Historic Market Size by Type (2017-2022) 24 4.2 Global NGS Based Clinical Diagnostics Forecasted Market Size by Type (2023-2028) 25 5 NGS Based Clinical Diagnostics Breakdown Data by Application 26 5.1 Global NGS Based Clinical Diagnostics Historic Market Size by Application (2017-2022) 26 5.2 Global NGS Based Clinical Diagnostics Forecasted Market Size by Application (2023-2028) 27 6 North America 28 6.1 North America NGS Based Clinical Diagnostics Market Size (2017-2028) 28 6.2 North America NGS Based Clinical Diagnostics Market Size by Type 28 6.2.1 North America NGS Based Clinical Diagnostics Market Size by Type (2017-2022) 28 6.2.2 North America NGS Based Clinical Diagnostics Market Size by Type (2023-2028) 29 6.2.3 North America NGS Based Clinical Diagnostics Market Share by Type (2017-2028) 29 6.3 North America NGS Based Clinical Diagnostics Market Size by Application 30 6.3.1 North America NGS Based Clinical Diagnostics Market Size by Application (2017-2022) 30 6.3.2 North America NGS Based Clinical Diagnostics Market Size by Application (2023-2028) 30 6.3.3 North America NGS Based Clinical Diagnostics Market Share by Application (2017-2028) 31 6.4 North America NGS Based Clinical Diagnostics Market Size by Country 31 6.4.1 North America NGS Based Clinical Diagnostics Market Size by Country (2017-2022) 31 6.4.2 North America NGS Based Clinical Diagnostics Market Share by Country (2023-2028) 32 6.4.3 United States 32 6.4.4 Canada 33 7 Europe 34 7.1 Europe NGS Based Clinical Diagnostics Market Size (2017-2028) 34 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 5 7.2 Europe NGS Based Clinical Diagnostics Market Size by Type 34 7.2.1 Europe NGS Based Clinical Diagnostics Market Size by Type (2017-2022) 34 7.2.2 Europe NGS Based Clinical Diagnostics Market Size by Type (2023-2028) 35 7.2.3 Europe NGS Based Clinical Diagnostics Market Share by Type (2017-2028) 35 7.3 Europe NGS Based Clinical Diagnostics Market Size by Application 36 7.3.1 Europe NGS Based Clinical Diagnostics Market Size by Application (2017-2022) 36 7.3.2 Europe NGS Based Clinical Diagnostics Market Size by Application (2023-2028) 36 7.3.3 Europe NGS Based Clinical Diagnostics Market Share by Application (2017-2028) 37 7.4 Europe NGS Based Clinical Diagnostics Market Size by Country 37 7.4.1 Europe NGS Based Clinical Diagnostics Market Size by Country (2017-2022) 37 7.4.2 Europe NGS Based Clinical Diagnostics Market Size by Country (2023-2028) 38 7.4.3 Germany 39 7.4.4 France 39 7.4.5 U.K. 40 7.4.6 Italy 40 7.4.7 Russia 40 7.4.8 Nordic Countries 40 8 Asia-Pacific 42 8.1 Asia-Pacific NGS Based Clinical Diagnostics Market Size (2017-2028) 42 8.2 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Type 42 8.2.1 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Type (2017-2022) 42 8.2.2 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Type (2023-2028) 43 8.2.3 Asia-Pacific NGS Based Clinical Diagnostics Market Share by Type (2017-2028) 43 8.3 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Application 44 8.3.1 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Application (2017-2022) 44 8.3.2 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Application (2023-2028) 44 8.3.3 Asia-Pacific NGS Based Clinical Diagnostics Market Share by Application (2017-2028) 45 8.4 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Region 45 8.4.1 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Region (2017-2022) 45 8.4.2 Asia-Pacific NGS Based Clinical Diagnostics Market Size by Region (2023-2028) 46 8.4.3 China 47 8.4.4 Japan 47 8.4.5 South Korea 48 8.4.6 Southeast Asia 48 8.4.7 India 49 8.4.8 Australia 49 9 Latin America 50 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 6 9.1 Latin America NGS Based Clinical Diagnostics Market Size (2017-2028) 50 9.2 Latin America NGS Based Clinical Diagnostics Market Size by Type 50 9.2.1 Latin America NGS Based Clinical Diagnostics Market Size by Type (2017-2022) 50 9.2.2 Latin America NGS Based Clinical Diagnostics Market Size by Type (2023-2028) 51 9.2.3 Latin America NGS Based Clinical Diagnostics Market Share by Type (2017-2028) 51 9.3 Latin America NGS Based Clinical Diagnostics Market Size by Application 52 9.3.1 Latin America NGS Based Clinical Diagnostics Market Size by Application (2017-2022) 52 9.3.2 Latin America NGS Based Clinical Diagnostics Market Size by Application (2023-2028) 52 9.3.3 Latin America NGS Based Clinical Diagnostics Market Share by Application (2017-2028) 53 9.4 Latin America NGS Based Clinical Diagnostics Market Size by Country 53 9.4.1 Latin America NGS Based Clinical Diagnostics Market Size by Country (2017-2022) 53 9.4.2 Latin America NGS Based Clinical Diagnostics Market Size by Country (2023-2028) 54 9.4.3 Mexico 54 9.4.4 Brazil 55 9.4.5 Brazil Market Analysis by Type and Application 55 10 Middle East & Africa 57 10.1 Middle East & Africa NGS Based Clinical Diagnostics Market Size (2017-2028) 57 10.2 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Type 57 10.2.1 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Type (2017-2022) 57 10.2.2 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Type (2023-2028) 58 10.2.3 Middle East & Africa NGS Based Clinical Diagnostics Market Share by Type (2017-2028)58 10.3 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Application 59 10.3.1 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Application (2017-2022) 59 10.3.2 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Application (2023-2028) 59 10.3.3 Middle East & Africa NGS Based Clinical Diagnostics Market Share by Application (2017-2028) 60 10.4 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Country 60 10.4.1 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Country (2017-2022)60 10.4.2 Middle East & Africa NGS Based Clinical Diagnostics Market Size by Country (2023-2028)61 10.4.3 Turkey 61 10.4.4 Saudi Arabia 62 10.4.5 UAE 62 11 Key Players Profiles 63 11.1 Janssen 63 11.1.1 Janssen Company Details 63 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 7 11.1.2 Janssen Business Overview 63 11.1.3 Janssen NGS Based Clinical Diagnostics Introduction 64 11.1.4 Janssen Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 64 11.1.5 Janssen Recent Development 64 11.2 Roche 65 11.2.1 Roche Company Details 65 11.2.2 Roche Business Overview 65 11.2.3 Roche NGS Based Clinical Diagnostics Introduction 65 11.2.4 Roche Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 66 11.2.5 Roche Recent Development 66 11.3 Qiagen 66 11.3.1 Qiagen Company Details 66 11.3.2 Qiagen Business Overview 67 11.3.3 Qiagen NGS Based Clinical Diagnostics Introduction 67 11.3.4 Qiagen Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 67 11.3.5 Qiagen Recent Development 68 11.4 ThermoFisher Scientific 68 11.4.1 ThermoFisher Scientific Company Details 68 11.4.2 ThermoFisher Scientific Business Overview 68 11.4.3 ThermoFisher Scientific NGS Based Clinical Diagnostics Introduction 69 11.4.4 ThermoFisher Scientific Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 69 11.4.5 ThermoFisher Scientific Recent Development 70 11.5 Oxford Gene Technology 70 11.5.1 Oxford Gene Technology Company Details 70 11.5.2 Oxford Gene Technology Business Overview 70 11.5.3 Oxford Gene Technology NGS Based Clinical Diagnostics Introduction 71 11.5.4 Oxford Gene Technology Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 71 11.5.5 Oxford Gene Technology Recent Development 71 11.6 Illumina 72 11.6.1 Illumina Company Details 72 11.6.2 Illumina Business Overview 72 11.6.3 Illumina NGS Based Clinical Diagnostics Introduction 72 11.6.4 Illumina Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 73 11.6.5 Illumina Recent Development 73 11.7 Pacific Biosciences 73 11.7.1 Pacific Biosciences Company Details 73 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 8 11.7.2 Pacific Biosciences Business Overview 74 11.7.3 Pacific Biosciences NGS Based Clinical Diagnostics Introduction 74 11.7.4 Pacific Biosciences Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 74 11.7.5 Pacific Biosciences Recent Development 75 11.8 Paradigm Diagnostics 75 11.8.1 Paradigm Diagnostics Company Details 75 11.8.2 Paradigm Diagnostics Business Overview 75 11.8.3 Paradigm Diagnostics NGS Based Clinical Diagnostics Introduction 76 11.8.4 Paradigm Diagnostics Revenue in NGS Based Clinical Diagnostics Business (2017-2022)76 11.8.5 Paradigm Diagnostics Recent Development 77 11.9 Innogene Kalbiotech 77 11.9.1 Innogene Kalbiotech Company Details 77 11.9.2 Innogene Kalbiotech Business Overview 77 11.9.3 Innogene Kalbiotech NGS Based Clinical Diagnostics Introduction 78 11.9.4 Innogene Kalbiotech Revenue in NGS Based Clinical Diagnostics Business (2017-2022)78 11.9.5 Innogene Kalbiotech Recent Development 78 11.10 Admera Health 79 11.10.1 Admera Health Company Details 79 11.10.2 Admera Health Business Overview 79 11.10.3 Admera Health NGS Based Clinical Diagnostics Introduction 79 11.10.4 Admera Health Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 80 11.10.5 Admera Health Recent Development 80 11.11 AITbiotech 80 11.11.1 AITbiotech Company Details 80 11.11.2 AITbiotech Business Overview 81 11.11.3 AITbiotech NGS Based Clinical Diagnostics Introduction 81 11.11.4 AITbiotech Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 81 11.11.5 AITbiotech Recent Development 82 11.12 Centogene 82 11.12.1 Centogene Company Details 82 11.12.2 Centogene Business Overview 82 11.12.3 Centogene NGS Based Clinical Diagnostics Introduction 83 11.12.4 Centogene Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 83 11.12.5 Centogene Recent Development 83 11.13 Phalanx Biotech Group 84 11.13.1 Phalanx Biotech Group Company Details 84 11.13.2 Phalanx Biotech Group Business Overview 84 11.13.3 Phalanx Biotech Group NGS Based Clinical Diagnostics Introduction 85 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 9 11.13.4 Phalanx Biotech Group Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 85 11.13.5 Phalanx Biotech Group Recent Development 85 11.14 iGenomX 86 11.14.1 iGenomX Company Details 86 11.14.2 iGenomX Business Overview 86 11.14.3 iGenomX NGS Based Clinical Diagnostics Introduction 86 11.14.4 iGenomX Revenue in NGS Based Clinical Diagnostics Business (2017-2022) 87 11.14.5 iGenomX Recent Development 87 12 Analyst's Viewpoints/Conclusions 88 13 Appendix 89 13.1 Research Methodology 89 13.1.1 Methodology/Research Approach 89 13.1.2 Data Source 92 13.2 Disclaimer 95 13.3 Author Details 95
List of Tables Table 1. Global NGS Based Clinical Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028................................................................................................................................. 1 Table 2. Key Players of DNA Sequencing....................................................................................................... 3 Table 3. Key Players of RNA Sequencing....................................................................................................... 3 Table 4. Key Players of Whole Genome Sequencing...................................................................................... 4 Table 5. Key Players of Whole Exome Sequencing ........................................................................................ 4 Table 6. Key Players of Other......................................................................................................................... 4 Table 7. Global NGS Based Clinical Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028................................................................................................................................. 5 Table 8. Global NGS Based Clinical Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 ..................................................................................................................................................... 10 Table 9. Global NGS Based Clinical Diagnostics Market Size by Region (2017-2022) & (US$ Million) ...........11 Table 10. Global NGS Based Clinical Diagnostics Market Share by Region (2017-2022)...............................11 Table 11. Global NGS Based Clinical Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)................................................................................................................................. 12 Table 12. Global NGS Based Clinical Diagnostics Market Share by Region (2023-2028).............................. 12 Table 13. NGS Based Clinical Diagnostics Market Trends ............................................................................ 12 Table 14. NGS Based Clinical Diagnostics Market Drivers............................................................................ 13 Table 15. NGS Based Clinical Diagnostics Market Challenges ..................................................................... 13 Table 16. NGS Based Clinical Diagnostics Market Restraints ....................................................................... 14 Table 17. Global NGS Based Clinical Diagnostics Revenue by Players (2017-2022) & (US$ Million) ............ 15 Table 18. Global NGS Based Clinical Diagnostics Market Share by Players (2017-2022) ............................. 16 Table 19. Global Top NGS Based Clinical Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Clinical Diagnostics as of 2021)........................................ 17 Table 20. Ranking of Global Top NGS Based Clinical Diagnostics Companies by Revenue (US$ Million) in 2021............................................................................................................................................. 18 Table 21. Global 5 Largest Players Market Share by NGS Based Clinical Diagnostics Revenue (CR5 and HHI) & (2017-2022) .............................................................................................................................. 20 Table 22. Key Players Headquarters and Area Served ................................................................................. 21 Table 23. Key Players NGS Based Clinical Diagnostics Product Solution and Service .................................. 21 Table 24. Date of Enter into NGS Based Clinical Diagnostics Market............................................................ 22 Table 25. Mergers & Acquisitions, Expansion Plans...................................................................................... 22 Table 26. Global NGS Based Clinical Diagnostics Market Size by Type (2017-2022) & (US$ Million)............ 24 Table 27. Global NGS Based Clinical Diagnostics Revenue Market Share by Type (2017-2022)................... 24 Table 28. Global NGS Based Clinical Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million) ..................................................................................................................................................... 25 Table 29. Global NGS Based Clinical Diagnostics Revenue Market Share by Type (2023-2028)................... 25 Table 30. Global NGS Based Clinical Diagnostics Market Size by Application (2017-2022) & (US$ Million)... 26 Table 31. Global NGS Based Clinical Diagnostics Revenue Market Share by Application (2017-2022) ......... 26 Table 32. Global NGS Based Clinical Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)................................................................................................................................. 27 Table 33. Global NGS Based Clinical Diagnostics Revenue Market Share by Application (2023-2028) ......... 27 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 11 Table 34. North America NGS Based Clinical Diagnostics Market Size by Type (2017-2022) & (US$ Million) 28 Table 35. North America NGS Based Clinical Diagnostics Market Size by Type (2023-2028) & (US$ Million) 29 Table 36. North America NGS Based Clinical Diagnostics Market Size by Application (2017-2022) & (US$ Million)................................................................................................................................. 30 Table 37. North America NGS Based Clinical Diagnostics Market Size by Application (2023-2028) & (US$ Million)................................................................................................................................. 30 Table 38. North America NGS Based Clinical Diagnostics Market Size by Country (2017-2022) & (US$ Million) ..................................................................................................................................................... 31 Table 39. North America NGS Based Clinical Diagnostics Market Size by Country (2023-2028) & (US$ Million) ..................................................................................................................................................... 32 Table 40. Europe NGS Based Clinical Diagnostics Market Size by Type (2017-2022) & (US$ Million)........... 34 Table 41. Europe NGS Based Clinical Diagnostics Market Size by Type (2023-2028) & (US$ Million)........... 35 Table 42. Europe NGS Based Clinical Diagnostics Market Size by Application (2017-2022) & (US$ Million).. 36 Table 43. Europe NGS Based Clinical Diagnostics Market Size by Application (2023-2028) & (US$ Million).. 36 Table 44. Europe NGS Based Clinical Diagnostics Market Size by Country (2017-2022) & (US$ Million) ...... 37 Table 45. Europe NGS Based Clinical Diagnostics Market Size by Country (2023-2028) & (US$ Million) ...... 38 Table 46. Asia-Pacific NGS Based Clinical Diagnostics Market Size by Type (2017-2022) & (US$ Million).... 42 Table 47. Asia-Pacific NGS Based Clinical Diagnostics Market Size by Type (2023-2028) & (US$ Million).... 43 Table 48. Asia-Pacific NGS Based Clinical Diagnostics Market Size by Application (2017-2022) & (US$ Million) ..................................................................................................................................................... 44 Table 49. Asia-Pacific NGS Based Clinical Diagnostics Market Size by Application (2023-2028) & (US$ Million) ..................................................................................................................................................... 44 Table 50. Asia-Pacific NGS Based Clinical Diagnostics Market Size by Region (2017-2022) & (US$ Million). 45 Table 51. Asia-Pacific NGS Based Clinical Diagnostics Market Size by Region (2023-2028) & (US$ Million). 46 Table 52. Latin America NGS Based Clinical Diagnostics Market Size by Type (2017-2022) & (US$ Million). 50 Table 53. Latin America NGS Based Clinical Diagnostics Market Size by Type (2023-2028) & (US$ Million). 51 Table 54. Latin America NGS Based Clinical Diagnostics Market Size by Application (2017-2022) & (US$ Million)................................................................................................................................. 52 Table 55. Latin America NGS Based Clinical Diagnostics Market Size by Application (2023-2028) & (US$ Million)................................................................................................................................. 52 Table 56. Latin America NGS Based Clinical Diagnostics Market Size by Country (2017-2022) & (US$ Million) ..................................................................................................................................................... 53 Table 57. Latin America NGS Based Clinical Diagnostics Market Size by Country (2023-2028) & (US$ Million) ..................................................................................................................................................... 54 Table 58. Brazil NGS Based Clinical Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028............................................................................................................................... 55 Table 59. Brazil NGS Based Clinical Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028............................................................................................................................... 56 Table 60. Middle East & Africa NGS Based Clinical Diagnostics Market Size by Type (2017-2022) & (US$ Million)................................................................................................................................. 57 Table 61. Middle East & Africa NGS Based Clinical Diagnostics Market Size by Type (2023-2028) & (US$ Million)................................................................................................................................. 58 Table 62. Middle East & Africa NGS Based Clinical Diagnostics Market Size by Application (2017-2022) & (US$ Million)................................................................................................................................. 59 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 12 Table 63. Middle East & Africa NGS Based Clinical Diagnostics Market Size by Application (2023-2028) & (US$ Million)................................................................................................................................. 59 Table 64. Middle East & Africa NGS Based Clinical Diagnostics Market Size by Country (2017-2022) & (US$ Million)................................................................................................................................. 60 Table 65. Middle East & Africa NGS Based Clinical Diagnostics Market Size by Country (2023-2028) & (US$ Million)................................................................................................................................. 61 Table 66. Janssen Company Details ............................................................................................................ 63 Table 67. Janssen Business Overview ......................................................................................................... 63 Table 68. Janssen NGS Based Clinical Diagnostics Product ........................................................................ 64 Table 69. Janssen Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)........ 64 Table 70. Janssen Recent Development ...................................................................................................... 64 Table 71. Roche Company Details ............................................................................................................... 65 Table 72. Roche Business Overview ............................................................................................................ 65 Table 73. Roche NGS Based Clinical Diagnostics Product ........................................................................... 65 Table 74. Roche Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)........... 66 Table 75. Roche Recent Development ......................................................................................................... 66 Table 76. Qiagen Company Details .............................................................................................................. 66 Table 77. Qiagen Business Overview........................................................................................................... 67 Table 78. Qiagen NGS Based Clinical Diagnostics Product .......................................................................... 67 Table 79. Qiagen Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million).......... 67 Table 80. Qiagen Recent Development ........................................................................................................ 68 Table 81. ThermoFisher Scientific Company Details..................................................................................... 68 Table 82. ThermoFisher Scientific Business Overview.................................................................................. 68 Table 83. ThermoFisher Scientific NGS Based Clinical Diagnostics Product ................................................. 69 Table 84. ThermoFisher Scientific Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)................................................................................................................................. 69 Table 85. ThermoFisher Scientific Recent Development............................................................................... 70 Table 86. Oxford Gene Technology Company Details................................................................................... 70 Table 87. Oxford Gene Technology Business Overview................................................................................ 70 Table 88. Oxford Gene Technology NGS Based Clinical Diagnostics Product ............................................... 71 Table 89. Oxford Gene Technology Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)................................................................................................................................. 71 Table 90. Oxford Gene Technology Recent Development ............................................................................. 71 Table 91. Illumina Company Details ............................................................................................................. 72 Table 92. Illumina Business Overview .......................................................................................................... 72 Table 93. Illumina NGS Based Clinical Diagnostics Product ......................................................................... 72 Table 94. Illumina Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)......... 73 Table 95. Illumina Recent Development ....................................................................................................... 73 Table 96. Pacific Biosciences Company Details............................................................................................ 73 Table 97. Pacific Biosciences Business Overview......................................................................................... 74 Table 98. Pacific Biosciences NGS Based Clinical Diagnostics Product........................................................ 74 Table 99. Pacific Biosciences Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)................................................................................................................................. 74 Table 100. Pacific Biosciences Recent Development.................................................................................... 75 Global NGS Based Clinical Diagnostics Market Insights, Forecast to 2028 Copyright © QYResearch | enquiry@qyresearch.com | www.qyresearch.com 13 Table 101. Paradigm Diagnostics Company Details...................................................................................... 75 Table 102. Paradigm Diagnostics Business Overview................................................................................... 75 Table 103. Paradigm Diagnostics NGS Based Clinical Diagnostics Product.................................................. 76 Table 104. Paradigm Diagnostics Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)................................................................................................................................. 76 Table 105. Paradigm Diagnostics Recent Development................................................................................ 77 Table 106. Innogene Kalbiotech Company Details........................................................................................ 77 Table 107. Innogene Kalbiotech Business Overview..................................................................................... 77 Table 108. Innogene Kalbiotech NGS Based Clinical Diagnostics Product.................................................... 78 Table 109. Innogene Kalbiotech Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)................................................................................................................................. 78 Table 110. Innogene Kalbiotech Recent Development .................................................................................. 78 Table 111. Admera Health Company Details................................................................................................. 79 Table 112. Admera Health Business Overview.............................................................................................. 79 Table 113. Admera Health NGS Based Clinical Diagnostics Product............................................................. 79 Table 114. Admera Health Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million) ..................................................................................................................................................... 80 Table 115. Admera Health Recent Development........................................................................................... 80 Table 116. AITbiotech Company Details ....................................................................................................... 80 Table 117. AITbiotech Business Overview .................................................................................................... 81 Table 118. AITbiotech NGS Based Clinical Diagnostics Product ................................................................... 81 Table 119. AITbiotech Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)... 81 Table 120. AITbiotech Recent Development................................................................................................. 82 Table 121. Centogene Company Details ...................................................................................................... 82 Table 122. Centogene Business Overview ................................................................................................... 82 Table 123. Centogene NGS Based Clinical Diagnostics Product................................................................... 83 Table 124. Centogene Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million).. 83 Table 125. Centogene Recent Development ................................................................................................ 83 Table 126. Phalanx Biotech Group Company Details.................................................................................... 84 Table 127. Phalanx Biotech Group Business Overview................................................................................. 84 Table 128. Phalanx Biotech Group NGS Based Clinical Diagnostics Product................................................ 85 Table 129. Phalanx Biotech Group Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million)................................................................................................................................. 85 Table 130. Phalanx Biotech Group Recent Development.............................................................................. 85 Table 131. iGenomX Company Details......................................................................................................... 86 Table 132. iGenomX Business Overview...................................................................................................... 86 Table 133. iGenomX NGS Based Clinical Diagnostics Product ..................................................................... 86 Table 134. iGenomX Revenue in NGS Based Clinical Diagnostics Business (2017-2022) & (US$ Million) .... 87 Table 135. iGenomX Recent Development................................................................................................... 87 Table 136. Research Programs/Design for This Report ................................................................................ 89 Table 137. Key Data Information from Secondary Sources ........................................................................... 92 Table 138. Key Data Information from Primary Sources................................................................................ 94
$600
HAVE A QUERY?
OUR CUSTOMER
